| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2011.639882 |
| P698 | PubMed publication ID | 22098406 |
| P50 | author | Leo Gordon | Q40235097 |
| Andrew D Zelenetz | Q46643038 | ||
| Ann S LaCasce | Q89672650 | ||
| P2093 | author name string | Jonathan W Friedberg | |
| Myron S Czuczman | |||
| Michael Millenson | |||
| Maria A Rodriguez | |||
| Gregory A Abel | |||
| Joyce C Niland | |||
| Ann Vanderplas | |||
| Allison L Crosby | |||
| P2860 | cites work | Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer | Q34087987 |
| The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma | Q34190099 | ||
| Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era | Q34621900 | ||
| High and rising health care costs. Part 2: technologic innovation | Q36154848 | ||
| The role of FDG-PET scans in patients with lymphoma | Q36914696 | ||
| 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence? | Q37031183 | ||
| Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network | Q37119439 | ||
| Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California | Q37148198 | ||
| Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies | Q42163806 | ||
| Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma | Q46094228 | ||
| The case against heavy PETing | Q46094239 | ||
| Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. | Q46435513 | ||
| Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography | Q46443809 | ||
| Is there a place for routine imaging for patients in complete remission from aggressive lymphoma? | Q53537649 | ||
| Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. | Q53540097 | ||
| P433 | issue | 6 | |
| P921 | main subject | database | Q8513 |
| diffuse large B-cell lymphoma | Q2626074 | ||
| B-cell lymphoma | Q4833719 | ||
| P304 | page(s) | 1113-1116 | |
| P577 | publication date | 2012-02-03 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database | |
| P478 | volume | 53 |
| Q47189782 | Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission |
| Q38052458 | Advances in oncologic imaging: update on 5 common cancers |
| Q52691819 | Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance. |
| Q39036785 | Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma |
| Q37040596 | Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. |
| Q28084956 | Next-generation surveillance strategies for patients with lymphoma |
| Q35723986 | Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. |
| Q38184954 | Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. |
| Q39142301 | Surveillance Scans in Lymphoma: Friend or Foe? |
| Q53083174 | Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma. |
| Q34775441 | The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review |
| Q34402503 | Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. |
| Q34283822 | Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas |
| Q45752281 | When and how to perform surveillance imaging in patients with lymphoma, and is it worth it? |
Search more.